Ignite Creation Date:
2024-05-05 @ 7:08 PM
Last Modification Date:
2024-10-26 @ 9:44 AM
Study NCT ID:
NCT00618046
Status:
COMPLETED
Last Update Posted:
2018-01-23
First Post:
2008-01-31
Brief Title:
Bioequivalency Study of Oxcarbazepine 600 mg Tablets Under Fed Conditions
Sponsor:
Roxane Laboratories
Organization:
West-Ward Pharmaceutical
Organization Data
Organization:
West-Ward Pharmaceutical
Class:
INDUSTRY
Study ID:
OXCA-T600-PVFD-2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Roxane Laboratories
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Elizabeth Ernst Director Drug Regulatory Affairs and Medical Affairs
Old Organization:
Roxane Laboratories Inc